Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 114 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Doumas, Michael [Clear All Filters]
Time in Therapeutic Range, as a Determinant of All-Cause Mortality in Patients With Hypertension..
J Am Heart Assoc. 6(11),
(2017).
(2017).
(2017). Antihypertensive Drug-Related Side Effects: Is It the Unique Indicator for Nonadherence?.
Am J Hypertens. 29(5), 662.
(2016). Current challenges in antihypertensive treatment in the elderly..
Pol Arch Med Wewn. 126(7-8), 540-51.
(2016). Depression in hypertensive patients: the role of comorbidities..
J Hypertens. 34(7), 1441.
(2016). Differential residual dyslipidemia/cardiovascular risk after statin treatment between Asian-Indians and western whites. Call for action..
Indian Heart J. 68(5), 596-598.
(2016). Discontinuation of Antihypertensive Treatment in Elderly Patients and Cognitive Function..
JAMA Intern Med. 176(3), 409.
(2016). Important practice lessons from the SPRINT study beyond the blood pressure goal: all well known and now confirmed..
J Am Soc Hypertens. 10(8), 613-7.
(2016). Lipids, Statins and Heart Failure: An Update..
Curr Pharm Des. 22(31), 4796-4806.
(2016). Renal Sympathetic Denervation: Hibernation or Resurrection?.
Cardiology. 135(2), 87-97.
(2016). Arterial Stiffness and Emerging Biomarkers: Still a Long Journey to Go..
Angiology. 66(10), 901-3.
(2015). Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update..
World J Gastroenterol. 21(22), 6820-34.
(2015). Erectile dysfunction in chronic kidney disease: From pathophysiology to management..
World J Nephrol. 4(3), 379-87.
(2015). Hyperuricemia as a risk factor for cardiovascular disease..
Expert Rev Cardiovasc Ther. 13(1), 19-20.
(2015). Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome..
World J Gastroenterol. 21(25), 7860-8.
(2015). Screening for Primary Aldosteronism: Whom and How?.
J Clin Hypertens (Greenwich). 17(7), 547-8.
(2015). Transcatheter Renal Sympathetic Denervation: Chasing a Chimera or a Matter of Technological Improvements?.
Cardiology. 131(3), 186-8.
(2015). Antihypertensive therapy after acute ischemic stroke..
JAMA. 311(22), 2333-4.
(2014). Combined angiotensin inhibition in diabetic nephropathy..
N Engl J Med. 370(8), 778-9.
(2014). Editorial: interventional management of hypertension and cardiovascular disease: the beginning of a new era?.
Curr Vasc Pharmacol. 12(1), 2-3.
(2014). Macro and microcirculation damage and incident hypertension: predictors of progression?.
J Hypertens. 32(5), 1154.
(2014). Non-interventional management of resistant hypertension..
World J Cardiol. 6(10), 1080-90.
(2014). Platelet activation in essential hypertension during exercise: pre- and post-treatment changes with an angiotensin II receptor blocker..
Am J Hypertens. 27(4), 571-8.
(2014). Prehypertension and the cardiometabolic syndrome: targeting several risk factors to achieve maximum benefit..
Expert Rev Cardiovasc Ther. 12(3), 295-6.
(2014).